LeadIQ logo
Learn more at LeadIQ.com
Allogene Therapeutics logo

Allogene Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States201-500 Employees

Allogene Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing allogeneic chimeric antigen receptor T cell products for cancer and autoimmune diseases. The firm aims to deliver readily available cell therapy on demand, with improved reliability and greater scale to reach more patients.

It operates within the biotechnology research sector, pursuing an off-the-shelf approach to CAR T therapies. In 2026, the company expanded the pivotal ALPHA3 Phase 2 trial to South Korea and Australia.

Find Allogene Therapeutics employees' phone numbers or email addresses

Allogene Therapeutics Global Highlights

Location
Employees

North America
309

Minus sign iconPlus sign icon
  • United States Of America
    307
  • Canada
    2

Asia
6

Minus sign iconPlus sign icon
  • India
    3
  • China
    1
  • United Arab Emirates
    1
  • Pakistan
    1

Europe
2

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    2

Allogene Therapeutics's Leadership

  • Chief Scientific Officer at Allogene Therapeutics
    B. S.
    Chief Scientific Officer
    Mobile Phone
  • Vice President Research& Development at Allogene Therapeutics
    A. A.
    Vice President Research& Development
    Mobile Phone
  • Senior Director, Supply Chain Business Owner at Allogene Therapeutics
    C. E.
    Senior Director, Supply Chain Business Owner
    Mobile Phone
  • Owner at Allogene Therapeutics
    S. F.
    Owner
    Mobile Phone
  • Senior Vice President at Allogene Therapeutics
    F. F.
    Senior Vice President
    Mobile Phone
  • Senior Vp Head:quality at Allogene Therapeutics
    D. T.
    Senior Vp Head:quality
    Mobile Phone
  • Executive Director Program Management Head Portfolio Management at Allogene Therapeutics
    H. E.
    Executive Director Program Management Head Portfolio Management
    Mobile Phone
  • Vice President, Corporate Counsel at Allogene Therapeutics
    L. S.
    Vice President, Corporate Counsel
    Mobile Phone

Allogene Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Quality Assurance
  • Operations
  • Analytics
  • Other
  • Biotechnology
  • Business
  • Legal
  • Sales

Contact profiles from Allogene Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Scientific Officer at Allogene Therapeutics
    B. S.
    Chief Scientific Officer
    Mobile Phone
    Jul 29, 2026
  • Senior Director, Supply Chain Business Owner at Allogene Therapeutics
    C. E.
    Senior Director, Supply Chain Business Owner
    Mobile Phone
    Jul 29, 2026
  • Owner at Allogene Therapeutics
    S. F.
    Owner
    Mobile Phone
    Jul 07, 2026
  • Senior Vice President at Allogene Therapeutics
    F. F.
    Senior Vice President
    Mobile Phone
    Bay
    Aug 30, 2026
  • Vice President Research& Development at Allogene Therapeutics
    A. A.
    Vice President Research& Development
    Mobile Phone
    Jun 09, 2026
  • Senior Vp Head:quality at Allogene Therapeutics
    D. T.
    Senior Vp Head:quality
    Mobile Phone
    Jun 09, 2026
  • Executive Director Program Management Head Portfolio Management at Allogene Therapeutics
    H. E.
    Executive Director Program Management Head Portfolio Management
    Mobile Phone
    Jun 09, 2026
  • Vice President, Corporate Counsel at Allogene Therapeutics
    L. S.
    Vice President, Corporate Counsel
    Mobile Phone
    Sep 18, 2025
  • Senior Vice President Clinical Development at Allogene Therapeutics
    R. B.
    Senior Vice President Clinical Development
    Mobile Phone
    Jun 09, 2026
  • Director, Hrbp at Allogene Therapeutics
    A. M. D.
    Director, Hrbp
    Mobile Phone
    Bay
    Jun 09, 2026

Frequently Asked Questions

What is Allogene Therapeutics known for?

Minus sign iconPlus sign iconAllogene Therapeutics was founded in 2017 and operates in the Biotechnology Research industry. You can contact Allogene Therapeutics's main corporate office by phone at
+1-650-457-****
. Explore Allogene Therapeutics's company overview page for more information.

What is Allogene Therapeutics's most common email format?

Minus sign iconPlus sign iconAllogene Therapeutics employees' email format typically follows the pattern of First.Last@allogene.com. Trying to find reliable and up-to-date employee contact data? Find more Allogene Therapeutics email formats with LeadIQ.

How many employees does Allogene Therapeutics have currently?

Minus sign iconPlus sign iconAllogene Therapeutics has approximately 221 employees as of August 2026. These team members are located across 3 continents, including North America, Asia and Europe.

Who are Allogene Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Allogene Therapeutics's key employees include:

  • Chief Scientific Officer: B. S.
  • Vice President Research& Development: A. A.
  • Senior Director, Supply Chain Business Owner: C. E.
  • Owner: S. F.
  • Senior Vice President: F. F.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.